Literature DB >> 15130954

Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.

K Sleegers1, G Roks, J Theuns, Y S Aulchenko, R Rademakers, M Cruts, W A van Gool, C Van Broeckhoven, P Heutink, B A Oostra, J C van Swieten, C M van Duijn.   

Abstract

Despite advances in elucidating the genetic epidemiology of Alzheimer's disease and frontotemporal dementia, the aetiology for most patients with dementia remains unclear. We examined the genetic epidemiology of dementia in a recent genetically isolated Dutch population founded around 1750. The series of 191 patients ascertained comprised 122 probable Alzheimer's disease patients with late onset and 17 with early onset, and 22 with possible Alzheimer's disease. It further included 10 patients with vascular dementia, nine with Lewy body dementia and six with frontotemporal dementia. All patients, except those with vascular dementia, were more closely related than healthy individuals from the same area. Clustering was strongest for patients with early-onset Alzheimer's disease or Lewy body dementia. Although 14% of late-onset Alzheimer's disease patients had evidence of autosomal dominant disease, consanguinity was found in three late-onset Alzheimer's disease patients, suggesting a recessive or polygenic model underlying the trait. We found no clustering of vascular dementia, implying a difference in genetic risk for late-onset Alzheimer's disease and vascular dementia. Mutations in known genes could not explain the occurrence of dementia, but the population attributable proportion of apolipoprotein E gene (APOE*4) was high (45%) due to a high frequency of APOE*4 carriers. Earlier identified regions on chromosomes 10 and 12, nor the effect of the alpha-2-macroglobulin (A2M) I/D polymorphism on Alzheimer's disease could be confirmed in our study. We did find evidence for association between the A2M D-allele and Lewy body dementia. Our data showed a strong familial clustering of various forms of dementia in this isolated Dutch population. A high percentage of late-onset Alzheimer's disease could be explained by APOE*4, but 55% of its origin is still unknown. Copyright 2004 Guarantors of Brain

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130954     DOI: 10.1093/brain/awh179

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  26 in total

1.  Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.

Authors:  Ebba Lohmann; Rita J Guerreiro; Nihan Erginel-Unaltuna; Nicole Gurunlian; Basar Bilgic; Hakan Gurvit; Hasmet A Hanagasi; Nga Luu; Murat Emre; Andrew Singleton
Journal:  Neurobiol Aging       Date:  2012-04-13       Impact factor: 4.673

2.  Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons.

Authors:  Gaël Nicolas; David Wallon; Camille Charbonnier; Olivier Quenez; Stéphane Rousseau; Anne-Claire Richard; Anne Rovelet-Lecrux; Sophie Coutant; Kilan Le Guennec; Delphine Bacq; Jean-Guillaume Garnier; Robert Olaso; Anne Boland; Vincent Meyer; Jean-François Deleuze; Hans Markus Munter; Guillaume Bourque; Daniel Auld; Alexandre Montpetit; Mark Lathrop; Lucie Guyant-Maréchal; Olivier Martinaud; Jérémie Pariente; Adeline Rollin-Sillaire; Florence Pasquier; Isabelle Le Ber; Marie Sarazin; Bernard Croisile; Claire Boutoleau-Bretonnière; Catherine Thomas-Antérion; Claire Paquet; Mathilde Sauvée; Olivier Moreaud; Audrey Gabelle; François Sellal; Mathieu Ceccaldi; Ludivine Chamard; Frédéric Blanc; Thierry Frebourg; Dominique Campion; Didier Hannequin
Journal:  Eur J Hum Genet       Date:  2015-08-05       Impact factor: 4.246

3.  The dystrophin gene and cognitive function in the general population.

Authors:  Dina Vojinovic; Hieab H H Adams; Sven J van der Lee; Carla A Ibrahim-Verbaas; Rutger Brouwer; Mirjam C G N van den Hout; Edwin Oole; Jeroen van Rooij; Andre Uitterlinden; Albert Hofman; Wilfred F J van IJcken; Annemieke Aartsma-Rus; GertJan B van Ommen; M Arfan Ikram; Cornelia M van Duijn; Najaf Amin
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

Review 4.  Epigenomics of Alzheimer's disease.

Authors:  David A Bennett; Lei Yu; Jingyun Yang; Gyan P Srivastava; Cristin Aubin; Philip L De Jager
Journal:  Transl Res       Date:  2014-05-16       Impact factor: 7.012

5.  Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study.

Authors:  M Schuur; P Henneman; J C van Swieten; M C Zillikens; I de Koning; A C J W Janssens; J C M Witteman; Y S Aulchenko; R R Frants; B A Oostra; K Willems van Dijk; C M van Duijn
Journal:  Eur J Epidemiol       Date:  2010-06-29       Impact factor: 8.082

Review 6.  Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease.

Authors:  Christopher Patterson; John W Feightner; Angeles Garcia; G-Y Robin Hsiung; Christopher MacKnight; A Dessa Sadovnick
Journal:  CMAJ       Date:  2008-02-26       Impact factor: 8.262

7.  High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients.

Authors:  Laila Abdullah; Cheryl Luis; Daniel Paris; Ghania Ait-ghezala; Benoit Mouzon; Elizabeth Allen; Julia Parrish; Myles A Mullan; Scott Ferguson; Marcie Wood; Fiona Crawford; Michael Mullan
Journal:  Mol Med       Date:  2009-12-08       Impact factor: 6.354

8.  Religious education and midlife observance are associated with dementia three decades later in Israeli men.

Authors:  Michal Schnaider Beeri; Michael Davidson; Jeremy M Silverman; James Schmeidler; Ramit Ravona Springer; Shlomo Noy; Uri Goldbourt
Journal:  J Clin Epidemiol       Date:  2008-06-06       Impact factor: 6.437

9.  A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population.

Authors:  Fan Liu; Alejandro Arias-Vásquez; Kristel Sleegers; Yurii S Aulchenko; Manfred Kayser; Pascual Sanchez-Juan; Bing-Jian Feng; Aida M Bertoli-Avella; John van Swieten; Tatiana I Axenovich; Peter Heutink; Christine van Broeckhoven; Ben A Oostra; Cornelia M van Duijn
Journal:  Am J Hum Genet       Date:  2007-05-29       Impact factor: 11.025

Review 10.  Genetics of Alzheimer's disease: a centennial review.

Authors:  Nilüfer Ertekin-Taner
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.